Endocrine, Metabolic & Immune Disorders - Drug Targets

Author(s): Ahmet Gorgel*, Cem Cankaya and Mehmet Tecellioglu

DOI: 10.2174/1871530318666180817143536

DownloadDownload PDF Flyer Cite As
Anti-Saccharomyces Cerevisiae as Unusual Antibody in Autoimmune Polyglandular Syndrome Type III: A Case Report

Page: [90 - 94] Pages: 5

  • * (Excluding Mailing and Handling)

Abstract

Backgraund and Objective: Anti-Saccharomyces Cerevisiae Antibodies (ASCA) that are considered to reflect immune response against increased intestinal permeability due to mucosal damage are among the serological markers of Crohn’s Disease.

Methods: This microbial seromarker was recently shown to be elevated in several autoimmune disorders such as celiac disease, autoimmune liver diseases, type 1 diabetes, and Graves’ disease. Despite that fact, ASCA seropositivity in Autoimmune Polyglandular Syndrome (APS) has never been reported before.

Results: Herein, we present a 46-year-old woman who has uveitis, autoimmune thyroiditis, and primary ovarian failure.

Conclusion: Based on the coexistence of these diseases, the patient was diagnosed with APS type III. Moreover, ASCA seropositivity was detected although she has no overt intestinal disease.

Keywords: Anti-Saccharomyces Cerevisiae Antibody (ASCA), Autoimmune Polyglandular Syndrome (APS) type III, uveitis, anti-double-stranded DNA, autoimmune hepatititis, antinuclear antibody.